Gene Name |
matrix metallopeptidase 12 (macrophage elastase) |
lipoprotein, Lp(a) |
Image |
|
No pdb structure |
Gene Ontology Annotations |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
|
Diseases |
|
|
GWAS |
|
|
Protein-Protein Interactions |
5 interactors:
APP
F12
LPA
PLAUR
TFPI
|
9 interactors:
APOH
CANX
CELA1
ELANE
FBLN5
FGB
FN1
LRP2
MMP12
|
Entrez ID |
4321 |
4018 |
HPRD ID |
03027 |
01063 |
Ensembl ID |
|
ENSG00000198670
|
Uniprot IDs |
P39900
|
|
PDB IDs |
1JIZ
1JK3
1OS2
1OS9
1RMZ
1ROS
1UTT
1UTZ
1Y93
1YCM
1Z3J
2HU6
2JXY
2K2G
2K9C
2KRJ
2OXU
2OXW
2OXZ
2POJ
2W0D
2WO8
2WO9
2WOA
2Z2D
3BA0
3EHX
3EHY
3F15
3F16
3F17
3F18
3F19
3F1A
3LIK
3LIL
3LIR
3LJG
3LK8
3LKA
3N2U
3N2V
3NX7
3RTS
3RTT
3TS4
3TSK
3UVC
4EFS
4GQL
4GR0
4GR3
4GR8
4GUY
4H30
4H49
4H76
4H84
4I03
4IJO
|
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
2h
behind
carbethoxyamino
carbodithioate
chromen
constitutive
coumarin
cpp
cxcl12
derivatives
docked
docking
evidently
fifth
great
hcc
hepatocellular
invasion
methylpyrrolidine
oxo
p50
p65
reporting
scoring
suppress
survivin
tumorigenesis
worldwide
yl
|
adequacy
amplified
apl
attributable
cdna
concordance
disagreement
ensure
external
hematological
hospitals
implementation
inadequacy
laboratories
malignancies
participating
pethema
pml
promyelocytic
rearrangements
rr
satisfactorily
scheme
sent
spanish
standardization
standardize
stressed
supporting
|
Tagcloud (Difference) ? |
2h
behind
carbethoxyamino
carbodithioate
chromen
constitutive
coumarin
cpp
cxcl12
derivatives
docked
docking
evidently
fifth
great
hcc
hepatocellular
invasion
methylpyrrolidine
oxo
p50
p65
reporting
scoring
suppress
survivin
tumorigenesis
worldwide
yl
|
adequacy
amplified
apl
attributable
cdna
concordance
disagreement
ensure
external
hematological
hospitals
implementation
inadequacy
laboratories
malignancies
participating
pethema
pml
promyelocytic
rearrangements
rr
satisfactorily
scheme
sent
spanish
standardization
standardize
stressed
supporting
|
Tagcloud (Intersection) ? |
|